Nano Group Ferro Group Stenting Control ANOVA, p value
  n=60 n=60 n=60  
Subset Stent proximal Pre-dilatation with balloon No preparation Stent proximal Pre-dilatation with balloon No preparation
No. patients n=6 (10.0%) n=9 (15.0%) n=45 (75.0%) n=7 (11.7%) n=11 (18.3%) n=42 (70.0%)
Total plaque-media volume (total atheroma volume - TAV) pre-procedure, mm3 179.9 ± 44.2 (95% CI: 180.2, 153.6-194.5) 179.6 ± 39.7 (95% CI: 181.8, 144.3-209.8) 180.9 ± 51.3 (95% CI: 182.6, 134.7-211.6) 189.5 ± 46.3 (95% CI: 184.8, 142.1-203.6) 188.2 ± 35.5 (95% CI: 182.9, 149.8-209.7) 189.7 ± 57.8 (95% CI: 184.2, 153.6-212.4) 175.8 ± 94.4 (95% CI: 112.9-234.8) NS
TAV post-procedure, mm3 147.7 ± 62.2 (95% CI: 146.2, 123.8-217.7) 148.9 ± 53.7 (95% CI: 144.9, 118.6-209.6) 152.1 ± 49.1 (95% CI: 143.7, 109.8-201.5) 144.7 ± 54.3 (95% CI:148.2,108.6-202.3) 142.3 ± 66.1 (95% CI: 147.6, 103.6-204.7) 146.2 ± 28.7 (95% CI: 149.4, 119.5-175.8) 179.1 ± 63.3 (95% CI: 176.1, 130.8-213.6) NS* 0.029#
TAV at 12-month follow-up, mm3 106.2 ± 21.1 (95% CI: 107.2, 86.9-123.4) 113.9 ± 32.5 (95% CI: 108.6, 84.7-145.6) 103.9 ± 26.9 (95% CI: 105.7, 79.8-131.8) 104.2 ± 32.3 (95% CI: 116.6, 75.7-137.6) 101.5 ± 53.8 (95% CI: 116.4, 69.5-155.4) 112.0 ± 27.8 (95% CI: 118.4, 86.5-140.3) 178.0 ± 52.6 (95% CI: 178.8, 122.4-226.3) <0.05*$ 0.029#
Lumen volume pre-procedure, mm3 83.3 ± 29.5 (95% CI: 80.4, 55.8-104.7) 82.4 ± 33.8 (95% CI: 79.4, 49.6-114.8) 85.2 ± 39.4 (95% CI: 82.8, 48.8-122.9) 78.3 ± 26.5 (95% CI: 79.8, 51.8-99.7) 79.2 ± 29.3 (95% CI: 80.6, 50.1-109.3) 81.5 ± 22.3 (95% CI: 77.8, 59.7-104.3) 81.4 ± 42.7 (95% CI: 82.2, 42.4-125.8) NS
Lumen volume post-procedure, mm3 95.6 ± 32.6 (95% CI: 96.5, 63.6-127.5) 95.4 ± 29.5 (95% CI: 94.6, 72.3-124.9) 96.3 ± 34.5 (95% CI: 97.3, 62.8-120.8) 98.2 ± 31.1 (95% CI: 98.3, 68.4-129.4) 97.5 ± 32.7 (95% CI: 66.8-128.6) 98.9 ± 21.6 (95% CI: 97.8, 77.4-119.3) 148.9 ± 45.5 (95% CI: 149.4, 103.4-186.6) NS* <0.01#
Lumen volume at 12-month follow-up, mm3 176.5 ± 45.5 (95% CI: 177.3, 131.0-220.4) 179.8 ± 41.5 (95% CI: 174.3, 138.3-224.6) 178.4 ± 42.2 (95% CI: 136.4-218.4) 177.2 ± 39.5 (95% CI: 177.7, 148.4-210.2) 179.5 ± 46.3 (95% CI: 181.6, 133.2-210.4) 176.8 ± 32.8 (95% CI: 176.1, 144.3-209.5) 158.4 ± 78.7 (95% CI: 159.9, 86.5-234.1) NS* <0.01#
*- p-value for the difference between Nano and Ferro groups;
$ - p-value for the difference between subsets of Nano and Ferro groups;
# - p-value for the difference between Nano, Ferro and Control groups
Table 2: Imaging follow-up at 12 months after intervention.